Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tingyu Hu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Marine Drugs|September 27, 2024
Bioactive Glial-Derived Neurotrophic Factor from a Safe Injectable Collagen-Alginate Composite Gel Rescues Retinal Photoreceptors from Retinal Degeneration in RabbitsTingyu Hu, Ting Zhou, Rajesh Kumar Goit, et al.
Cell & Bioscience|April 10, 2026
Integrating single-cell and spatial transcriptomics to reveal the spatiotemporal dynamics of retinal cells during ischemia-reperfusion injury progression in ratsYijia Huang, Junhong Guo, Fei Yao, et al.
Journal of Affective Disorders|March 6, 2021
Prevalence and factors associated with anxiety and depressive symptoms among patients hospitalized with hematological malignancies after chimeric antigen receptor T-cell (CAR-T) therapy: A cross-sectional studyHongyuan Dai, Shuya Xu, Jing Han, et al.
Analytical Chemistry|November 21, 2025
Ultrahigh-Power Sonicator Lysis Enables Deep Proteomic Profiling of Hair Shafts for Fetal Growth Restriction Biomarker DiscoveryYuhong Hu, Tingyu Hu, Juan Chen, et al.
Journal of Virology|November 24, 2025
Direct airway delivery of a humanized anti-H7N9 neutralizing antibody broadly protects against divergent H7 influenza viruses in the mouse modelWang Yu, Xiaozheng He, Jiangyan Zhao, et al.
Scientific Reports|May 15, 2024
Evaluating the psychometric properties of the simplified Chinese version of PROMIS-29 version 2.1 in patients with hematologic malignanciesQianqian Zhang, Jinying Zhao, Yating Liu, et al.
The Lancet. Haematology|April 14, 2025
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trialJieyun Xia, Qian Sun, Dian Zhou, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Marine Drugs|September 27, 2024
Bioactive Glial-Derived Neurotrophic Factor from a Safe Injectable Collagen-Alginate Composite Gel Rescues Retinal Photoreceptors from Retinal Degeneration in RabbitsTingyu Hu, Ting Zhou, Rajesh Kumar Goit, et al.
Cell & Bioscience|April 10, 2026
Integrating single-cell and spatial transcriptomics to reveal the spatiotemporal dynamics of retinal cells during ischemia-reperfusion injury progression in ratsYijia Huang, Junhong Guo, Fei Yao, et al.
Journal of Affective Disorders|March 6, 2021
Prevalence and factors associated with anxiety and depressive symptoms among patients hospitalized with hematological malignancies after chimeric antigen receptor T-cell (CAR-T) therapy: A cross-sectional studyHongyuan Dai, Shuya Xu, Jing Han, et al.
Analytical Chemistry|November 21, 2025
Ultrahigh-Power Sonicator Lysis Enables Deep Proteomic Profiling of Hair Shafts for Fetal Growth Restriction Biomarker DiscoveryYuhong Hu, Tingyu Hu, Juan Chen, et al.
Journal of Virology|November 24, 2025
Direct airway delivery of a humanized anti-H7N9 neutralizing antibody broadly protects against divergent H7 influenza viruses in the mouse modelWang Yu, Xiaozheng He, Jiangyan Zhao, et al.
Scientific Reports|May 15, 2024
Evaluating the psychometric properties of the simplified Chinese version of PROMIS-29 version 2.1 in patients with hematologic malignanciesQianqian Zhang, Jinying Zhao, Yating Liu, et al.
The Lancet. Haematology|April 14, 2025
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trialJieyun Xia, Qian Sun, Dian Zhou, et al.
Pageof 2